The Japanese government intends to take “strict action” against Bayer after the drug maker acknowledged three employees “inappropriately” accessed patient data as part of a plan to promote its Xarelto blood thinner, according to Pharma Japan. In response, Bayer executives will voluntarily return 10 percent of their salaries for three months for failing to properly oversee employees.
The moves come in response to a festering scandal in which Bayer employees used patient data from two surveys in a medical journal paper and promotional materials around the time of the Xarelto product launch in 2012. A former Bayer sales rep claimed he was instructed to gather data from dozens of patients about blood thinner dosing and related health matters.
About the Author Reprints
